Workboat Indexes

Bioxcel Therapeutics Inc (NQ: BTAI )

0.6685 -0.0415 (-5.85%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 20, 2024 Add to My Watchlist

Price and Volume

Volume	333,404
Open	0.7100
Bid (Size)	0.6685 (1)
Ask (Size)	0.6900 (1)
Prev. Close	0.7100
Today's Range	0.6610 - 0.7200
52wk Range	0.6453 - 5.620
Shares Outstanding	40,743,762
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BTAI Stock Earnings: BioXcel Therapeutics Beats EPS, Beats Revenue for Q2 2024

August 06, 2024

BTAI stock results show that BioXcel Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

BioXcel Therapeutics' Approved Drug For Bipolar Disorders/Schizophrenia Shows No Evidence Of Worsening Or Withdrawal In Post-Marketing Study

June 25, 2024

BioXcel Therapeutics shares topline results from an Igalmi (dexmedetomidine) sublingual film study. The 180 mcg dose demonstrated favorable safety and efficacy in reducing agitation symptoms.

Via Benzinga

Performance

YTD	-77.18%	-77.18%
1 Month	-44.29%	-44.29%
3 Month	-66.74%	-66.74%
6 Month	-80.95%	-80.95%
1 Year	-83.16%	-83.16%

More News

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

June 25, 2024

Via InvestorPlace

BTAI Stock Earnings: BioXcel Therapeutics Misses EPS, Beats Revenue for Q1 2024

May 09, 2024

Via InvestorPlace

BioXcel Therapeutics's Earnings Outlook

March 11, 2024

Via Benzinga

Why BioXcel Therapeutics Shares Are Falling Today

February 09, 2024

Via Benzinga

AI Surge Has Ended: All 7 AI Stock Categories Declined This Week

April 13, 2024

Via Talk Markets

Six Of Seven AI Stock Categories Increased This Week

March 23, 2024

Via Talk Markets

7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode

March 07, 2024

Via InvestorPlace

AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD

March 04, 2024

Via Talk Markets

Earnings Scheduled For March 12, 2024

March 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session

February 27, 2024

Via Benzinga

AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics

February 19, 2024

Via Talk Markets

12 Health Care Stocks Moving In Wednesday's Intraday Session

February 14, 2024

Via Benzinga

Leading The Charge: Tonix Pharmaceuticals And The Future Of CNS Therapeutics

February 13, 2024

Via Get News

Why BioXcel Therapeutics Shares Are Rising Tuesday

February 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session

February 13, 2024

Via Benzinga

Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies

February 14, 2024

Via FinancialNewsMedia

12 Health Care Stocks Moving In Monday's Pre-Market Session

February 12, 2024

Via Benzinga

Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies

February 14, 2024

From FN Media Group LLC

Via GlobeNewswire

BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

February 09, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session

February 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session

February 09, 2024

Via Benzinga

Why Is CleanSpark (CLSK) Stock Up 27% Today?

February 09, 2024

Via InvestorPlace

Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session

February 09, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.